TY - JOUR
T1 - Improvements in risk factor control among persons with diabetes in the United States
T2 - Evidence and implications for remaining life expectancy
AU - Hoerger, Thomas J.
AU - Zhang, Ping
AU - Segel, Joel E.
AU - Gregg, Edward W.
AU - Narayan, K. M.Venkat
AU - Hicks, Katherine A.
N1 - Funding Information:
This research was supported by funding (Contract # 200-2002-00776) from CDC, which supported the study's design and implementation. The findings and conclusions in this article are solely those of the authors and do not necessarily reflect the official position of CDC. Steven Couper provided research assistance.
PY - 2009/12
Y1 - 2009/12
N2 - Aims: To examine whether A1c, blood pressure, and cholesterol values changed for U.S. adults with diagnosed diabetes between 1988-1994 and 2005-2006. We then project the impact of these changes on life expectancy and diabetes-related complications. Methods: We estimated changes in hemoglobin A1c, blood pressure, and total cholesterol between 1988-1994 and 2005-2006 using regression analysis and data from the National Health and Nutrition Examination Survey. We projected the potential effects on life expectancy and complications using the CDC-RTI Diabetes Cost-Effectiveness Model. Results: A1c fell by 0.68 percentage points (P = 0.001) among U.S. adults with diagnosed diabetes. Among those with diabetes and hypertension, systolic and diastolic blood pressure fell by 5.66 and 8.15 mmHg, respectively (P = 0.005 and P = 0.001). Among those with diabetes and high cholesterol, total cholesterol fell by 36.41 mg/dL (P = 0.001). These improvements were projected to increase life expectancy for persons with newly diagnosed diabetes by 1.0 year. Conclusions: Risk factor control has improved in the United States. Persons newly diagnosed with type 2 diabetes in 2005 have a better prognosis than persons diagnosed with diabetes 11 years earlier.
AB - Aims: To examine whether A1c, blood pressure, and cholesterol values changed for U.S. adults with diagnosed diabetes between 1988-1994 and 2005-2006. We then project the impact of these changes on life expectancy and diabetes-related complications. Methods: We estimated changes in hemoglobin A1c, blood pressure, and total cholesterol between 1988-1994 and 2005-2006 using regression analysis and data from the National Health and Nutrition Examination Survey. We projected the potential effects on life expectancy and complications using the CDC-RTI Diabetes Cost-Effectiveness Model. Results: A1c fell by 0.68 percentage points (P = 0.001) among U.S. adults with diagnosed diabetes. Among those with diabetes and hypertension, systolic and diastolic blood pressure fell by 5.66 and 8.15 mmHg, respectively (P = 0.005 and P = 0.001). Among those with diabetes and high cholesterol, total cholesterol fell by 36.41 mg/dL (P = 0.001). These improvements were projected to increase life expectancy for persons with newly diagnosed diabetes by 1.0 year. Conclusions: Risk factor control has improved in the United States. Persons newly diagnosed with type 2 diabetes in 2005 have a better prognosis than persons diagnosed with diabetes 11 years earlier.
UR - http://www.scopus.com/inward/record.url?scp=70449527447&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449527447&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2009.09.017
DO - 10.1016/j.diabres.2009.09.017
M3 - Article
C2 - 19833403
AN - SCOPUS:70449527447
SN - 0168-8227
VL - 86
SP - 225
EP - 232
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
IS - 3
ER -